Agentix (AGTX) Cash from Operations Growth (3y) (2016 - 2026)
Agentix (AGTX) Cash from Operations Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -0.27% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -7.35% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 16.85% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 52.90% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 96.08% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -24.76% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.23% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 6.22% |
| 10 | Agentix | 801,339.00 | 801,301.00 | - | 25.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.10% |
| Mar 31, 2026 | 33.10% |
| Dec 31, 2025 | -245.65% |
| Sep 30, 2025 | 27.31% |
| Jun 30, 2025 | -1,291.14% |
| Nov 30, 2021 | 76.15% |
| Aug 31, 2021 | 36.36% |
| Feb 28, 2021 | -983.80% |
| Nov 30, 2020 | -104.32% |
| Nov 30, 2019 | 88.40% |
| Aug 31, 2019 | 26.89% |
| May 31, 2019 | -24.61% |
| Feb 28, 2019 | -183.51% |
| Nov 30, 2018 | -79.02% |
| Aug 31, 2018 | -6.06% |
| May 31, 2018 | 69.13% |
| Feb 28, 2018 | 26.01% |
| Nov 30, 2017 | 24.62% |
| Feb 28, 2017 | 28.44% |
| Nov 30, 2016 | 26.60% |